LIVESEY CONTRACTING & MAINTENANCE LIMITED
Company number 06682631 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: A-
Explanation: Livesey Contracting & Maintenance Limited is in excellent financial health, demonstrating the vitality and resilience of a well-conditioned patient. The business has just delivered a record-breaking year, with robust revenue growth, significantly improved cash reserves, and steady profit margins. The slight deduction from a perfect score accounts for the inherent volatility and leverage typically associated with the construction sector, which requires ongoing monitoring despite the company's current strong immunity to market shocks.
Key Vital Signs
- Heartbeat (Revenue): £21.99 Million. The company's financial pulse is strong and accelerating, representing a 14.9% increase from the previous year (£19.14M). This indicates a healthy, growing demand for its services.
- Blood Pressure (Cash Position): £1.14 Million. This is a massive improvement from £276,829 in the prior year. Cash is the lifeblood of any construction business, and this 313% increase suggests the company is generating healthy operating cash flow and managing its working capital effectively.
- Cholesterol (Total Liabilities): £4.53 Million. While total liabilities have grown, they are comfortably supported by £8.59 Million in total assets. The debt-to-equity ratio (leverage) is approximately 1.45:1, which is a normal, healthy reading for a medium-sized construction firm—enough leverage to fuel growth, but not so high that it causes circulatory strain.
- Stamina (Net Assets): £3.12 Million. Up from £2.77 Million, representing a 12.6% year-over-year increase in retained strength. The business is building a solid foundation of equity.
- Metabolism (Profit Margins): Gross Margin 22.2% | Net Margin 5.3%. The company is efficiently converting its revenue into profit. A 5.3% net margin is highly respectable in the building completion and finishing sector, where margins are notoriously thin.
Diagnosis
Symptoms Analysis: The financial data reveals a business that has successfully overcome prior period tightness and is currently in peak condition. The most striking symptom is the dramatic recovery in cash reserves. In 2023, the company held only £197,658 in cash, which for an £18.6M turnover business was a dangerously low "blood pressure" reading—indicating potential working capital stress. By 2025, cash has surged to over £1.1M, showing that the business has significantly improved its collections, cost discipline, and operational efficiency.
Overall Assessment: The patient is suffering from no chronic financial illnesses. The "one-stop-shop" model appears to be generating a strong immune response against the typical sector ailments of material inflation and operational complexity. Net assets have grown consistently year-over-year since 2016, showing a long-term pattern of financial healing and strengthening rather than just a short-term spike. The company is well-capitalized, profitable, and highly liquid relative to its recent history.
Prognosis
The future outlook is highly positive. With a record-breaking FY25 and a strong order book moving into 2026, the business has excellent momentum. The construction sector remains susceptible to macroeconomic "infections" such as material cost inflation and labor shortages, but LCM Group has demonstrated the operational "antibodies" to mitigate these risks through tight purchasing controls and strategic sourcing. Assuming the continuation of current management disciplines, the company is well-positioned for sustainable, profitable growth without the need for emergency capital interventions.
Recommendations
- Cardio Workout (Grow Recurring Revenue): As identified in the company's own strategic priorities, shifting the revenue mix toward long-term maintenance and service-level agreements will act like steady cardiovascular exercise—ensuring a consistent, predictable cash flow heartbeat rather than the sporadic spikes associated purely with project-based work.
- Maintain the Diet (Protect Cash Reserves): The transition from £276k to £1.14M in cash is a phenomenal achievement. To avoid a relapse into cash flow tightness, maintain strict working capital management. Ensure that the integrated IT platform is used to aggressively monitor debtor days and prevent cash from getting trapped in unpaid invoices.
- Immune System Boost (Supply Chain & Inflation Management): The company has improved its gross margin from 21.7% to 22.2% through cost discipline. Continue to treat supply chain volatility as a potential virus. Lock in supplier pricing where possible and maintain the expanded purchasing team to keep the "infection" of material inflation at bay.
- Vital Sign Monitoring (IT System Optimization): The business has invested heavily in new IT systems. Ensure these systems are fully utilized to provide real-time dashboards on project profitability and cash flow. A good diagnostic tool ensures the business catches any minor health issues before they become major problems.